CYTEK BIOSCIENCES INC (CTKB:NASDAQ)
$5.89 0.3 (5.3667%)
Analysed CYTEK BIOSCIENCES INC (CTKB:NASDAQ) News Sources
Cytek (CTKB) Q2 2026 Earnings Call Transcript
12-08-2026
fool.com
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
21-08-2026
yahoo.com
Cytek Biosciences to Participate in Upcoming Investor Conferences
01-09-2026
yahoo.com
Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing
09-09-2026
yahoo.com
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
09-09-2026
yahoo.com
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?
17-09-2026
yahoo.com
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
23-09-2026
yahoo.com
Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability
29-09-2026
yahoo.com
Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
21-10-2026
yahoo.com
Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh Profitability
25-10-2026
yahoo.com
What is the current price of CYTEK BIOSCIENCES INC (CTKB:NASDAQ)?
The current price of CYTEK BIOSCIENCES INC (CTKB:NASDAQ) is $5.89.
CYTEK BIOSCIENCES INC (CTKB:NASDAQ) absolute price change since previous trading day?
The absolute price change of CYTEK BIOSCIENCES INC (CTKB:NASDAQ) since the previous trading day is $0.3.
CYTEK BIOSCIENCES INC (CTKB:NASDAQ) percentage price change since previous trading day?
The percentage price change of CYTEK BIOSCIENCES INC (CTKB:NASDAQ) since the previous trading day is 5.3667%.
What is the most recent average sentiment score for CYTEK BIOSCIENCES INC (CTKB:NASDAQ)?
The most recent average sentiment score for CYTEK BIOSCIENCES INC (CTKB:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for CYTEK BIOSCIENCES INC (CTKB:NASDAQ)?
The most recent sentiment for CYTEK BIOSCIENCES INC (CTKB:NASDAQ) is .
SEC-8K** Filing Available For CYTEK BIOSCIENCES INC (CTKB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.